Orexigen

Arena Approaches 50% Institutional Ownership
Seeking Alpha
Thu, 08/15/13 - 02:53 pm
Arena Pharmaceuticals
Vivus
Orexigen
Belviq
Contrave
Qsymia
Orexigen Investigated By Class Action Firm
Seeking Alpha
Tue, 08/13/13 - 10:51 am
Orexigen
Class Action Lawsuit
Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
Yahoo
Wed, 08/7/13 - 09:45 am
earnings
Orexigen
Vivus Weight-Loss Pill Scripts Are Surging
TheStreet.com
Tue, 07/30/13 - 01:30 pm
Vivus
obesity
Qsymia
Arena Pharmaceuticals
Orexigen
The Best- And Worst-Performing Biotech Stocks July 19 To July 26
Forbes
Mon, 07/29/13 - 12:27 pm
TearLab
Array Biopharma
Furiex Pharmaceuticals
InterMune
Prosensa
Boston Scientific
Orexigen
Momenta
Ironwood
INSYS Therapeutics
Sequenom
OncoMed
Abraxis
Sarepta
Epizyme
Tesaro
Synta Pharmaceuticals
Bluebird Bio
Exelixis
Lexicon Pharmaceuticals
Intercept Pharma
GTx
The Obesity Drug Battle
Seeking Alpha
Wed, 07/10/13 - 01:56 pm
obesity
Belviq
Arena Pharmaceuticals
Contrave
Orexigen
Vivus
Qsymia
Roche
Xenical
GSK
The Hidden Way to Invest in Obesity
Motley Fool
Sun, 06/30/13 - 10:40 am
Orexigen
obesity
weight loss
Contrave
Is The Anti-Obesity Space Going To Get Crowded?
Seeking Alpha
Mon, 06/24/13 - 10:52 am
obesity
Arena Pharmaceuticals
Orexigen
Vivus
beloranib
Zagfen
Contrave
Belviq
Qsymia
Obesity Sector Gets New Shoes
Seeking Alpha
Thu, 06/20/13 - 07:48 am
obesity
Arena Pharmaceuticals
Vivus
Orexigen
Contrave
Belviq
Qsymia
2 Biotech Approval Outcomes That Might Affect You
Motley Fool
Wed, 06/19/13 - 11:08 am
drug approvals
Afrezza
MannKind
Contrave
Orexigen
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:41 am
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
Arena And Vivus Investors: Do Not Fear A Market Correction
Seeking Alpha
Tue, 06/4/13 - 12:38 pm
Vivus
Arena Pharmaceuticals
Orexigen
obesity
Arena: Marketing An Anti-Obesity Drug
Seeking Alpha
Thu, 05/30/13 - 09:03 am
Arena Pharmaceuticals
obesity
Vivus
Orexigen
Belviq
Qsymia
Eisai
Is Novo A Threat To Arena, Vivus, And Orexigen?
Seeking Alpha
Thu, 05/30/13 - 09:02 am
obesity
Novo Nordisk
Victoza
Arena Pharmaceuticals
Vivus
Orexigen
3 Pipeline Obesity Treatments You Should Watch
Motley Fool
Thu, 05/23/13 - 12:03 pm
obesity
Vivus
Orexigen
Contrave
Belviq
tesofensine
Neurosearch
Qsymia
Arena Pharmaceuticals
Will Obesity Drugs Gain Soon?
Motley Fool
Wed, 05/15/13 - 09:50 am
obesity
Novo Nordisk
Arena Pharmaceuticals
Vivus
Orexigen
Belviq
Contrave
Qsymia
Victoza
Is Orexigen Therapeutics Burning Too Much Cash?
Motley Fool
Wed, 05/8/13 - 09:13 am
Orexigen
Vivus And Anti-Obesity Sector Benefit From New Insurance Deal
Seeking Alpha
Wed, 05/1/13 - 09:54 am
Vivus
obesity
Orexigen
Arena Pharmaceuticals
Qsymia
Medco
Exciting Catalysts Approaching for This Bet
Motley Fool
Sun, 04/28/13 - 12:07 pm
obesity
weight loss
Arena Pharmaceuticals
Vivus
Orexigen
Belviq
Qsymia
Arena Faces A Convergence Of DEA And European Decisions
Seeking Alpha
Wed, 04/24/13 - 10:25 am
Arena Pharmaceuticals
Europe
DEA
Eisai
Vivus
Orexigen

Pages